Definitive proxy statements

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)

5 Months Ended

7 Months Ended

12 Months Ended

Jun. 30, 2024

Jan. 31, 2024

Jun. 30, 2025

Jun. 30, 2024

Jun. 30, 2023

Jun. 30, 2022

Jun. 30, 2021

Pay vs Performance Disclosure [Table]

Pay vs Performance Disclosure, Table

Pay vs. Performance

As required by SEC rules, we are providing the following information about the relationship between executive compensation actually paid (as defined by SEC rules) and certain financial performance measures. For information about how our Compensation Committee seeks to align executive compensation with the Company’s performance, see “Compensation discussion and analysis.” The amounts in the table below are calculated in accordance with SEC rules and do not represent amounts actually earned or realized by our NEOs.


Fiscal Year	Summary Compensation Table Total for CEO⁽¹⁾⁽²⁾ Mr. Kelderman			Compensation actually paid to CEO⁽¹⁾⁽²⁾ Mr. Kelderman			Summary Compensation Table Total for CEO⁽¹⁾ Mr. Kummeth		Compensation actually paid to CEO⁽¹⁾ Mr. Kummeth			Average Summary Compensation Table Total for Non-PEO NEOs⁽²⁾			Average Compensation actually Paid to Non-PEO NEOs⁽²⁾			Value of Initial Fixed $100 Investment based on:						Company- selected Measure (Organic Revenue)⁽⁵⁾
Fiscal Year																		Company TSR		Peer Group TSR⁽³⁾		Net Income⁽⁴⁾
2025	$	8,151,181		$	2,471,713		$	—	$	—		$	3,748,508		$	2,883,223		$	79.49	$	103.58	$	73,400,000	$	1,210,000
2024		2,636,900	⁽¹¹⁾		2,828,450	⁽¹¹⁾		6,792,945		4,821,823			3,303,421	⁽¹²⁾		3,651,652	⁽¹²⁾		110.17		131.47		168,105,000		1,147,100
2023		—			—			30,584,644		4,684,176			2,258,387			2,424,680			124.96		126.72		285,442,000		1,134,700
2022		—			—			15,370,549		(6,349,624	)		3,223,063			(2,680,481	)		132.17		129.72		263,099,000		1,113,600
2021		—			—			15,889,896		105,676,083			4,950,600			26,444,391			171.17		147.61		139,585,000		915,900

Company Selected Measure Name

organic revenue

Named Executive Officers, Footnote

(1)

The Company had two CEOs during fiscal year 2024. Effective November 1, 2023, Mr. Kelderman was appointed the role of Chief Executive Officer and assumed the role on February 1, 2024. Mr. Kummeth left his position as Chief Executive Officer effective February 1, 2024 and remained with the company as a Senior Advisor through July 1, 2024. Mr. Kelderman was our CEO for the fully fiscal year 2025. Mr. Kummeth was our CEO for the full fiscal years 2021 through 2023.

(2)

For fiscal year 2024, Mr. Kelderman held his position as President, Diagnostics and Genomics prior to assuming the position of CEO on February 1, 2024. Therefore, any compensation granted or vested prior to assuming the position of CEO is included in the average non-PEO NEO compensation for fiscal year 2024.

Adjustment To PEO Compensation, Footnote


	FY25						FY24									FY23						FY22
	CEO			Non-PEO NEOs			CEO Mr. Kelderman			CEO Mr. Kummeth			Non-PEO NEOs			CEO			Non-PEO NEOs			CEO			Non-PEO NEOs
Total from Summary Compensation Table ⁽ⁱ⁾		8,151,181			3,748,508			2,636,900	⁽⁶⁾		6,792,945			3,303,421	⁽⁷⁾		30,584,644			2,258,387			15,370,549			3,223,063
Subtract: Grant date fair value of option and stock awards granted in the fiscal year ⁽ⁱⁱ⁾		(5,862,791	)		(1,264,411	)		(2,152,815	)⁽⁶⁾		(5,000,028	)		(1,349,102	)⁽⁷⁾		(29,325,210	)		(850,075	)		(10,299,362	)		(949,840	)
Add: Fair value at fiscal year end of outstanding and unvested option and stock awards granted in the fiscal year ⁽ⁱⁱⁱ⁾		3,511,656			1,569,604			2,344,977			4,234,157			2,565,518			4,318,227	⁽⁸⁾		1,382,025			6,472,546			1,106,688
Add/Subtract: Year-over-Year change in fair value of outstanding and unvested option and stock awards granted in prior fiscal years ^(iv)		(3,442,309	)		(1,234,677	)		—			(1,241,718	)		(847,318	)		(6,132,401	)		(877,492	)		(22,021,635	)		(5,636,997	)
Add: Vesting date fair value of option and stock awards granted and vesting during the fiscal year ^(v)		—			—			—			—			—			—			—			—			—
Add/Subtract: Change as of the vesting date (from the end of the prior fiscal year) in fair value of option and stock awards granted in any prior fiscal year for which vesting conditions were satisfied during the fiscal year, less the fair value (as of end of prior fiscal year) of prior year awards that failed to vest ^(vi)		113,976			64,200			—			36,468			(20,867	)		5,238,918			633,346			4,128,278			469,566
Subtract: Awards granted in prior years that did not meet the applicable vesting conditions during the fiscal year ^(vii)		—			—			—			—			—			—			(121,511	)		—			(892,961	)
Compensation Actually Paid		2,471,713			2,883,223			2,828,450	⁽⁶⁾		4,821,823			3,651,652	⁽⁷⁾		4,684,176			2,424,680			(6,349,624	)		(2,680,481	)


	FY21
	CEO			Non-PEO NEOs
Total from Summary Compensation Table ⁽ⁱ⁾		15,889,896			4,950,600
Subtract: Grant date fair value of option and stock awards granted in the fiscal year ⁽ⁱⁱ⁾		(11,199,803	)		(1,722,395	)
Add: Fair value at fiscal year end of outstanding and unvested option and stock awards granted in the fiscal year ⁽ⁱⁱⁱ⁾		30,362,017			10,602,750
Add/Subtract: Year-over-Year change in fair value of outstanding and unvested option and stock awards granted in prior fiscal years ^(iv)		64,935,446			11,789,651
Add: Vesting date fair value of option and stock awards granted and vesting during the fiscal year ^(v)		—			—
Add/Subtract: Change as of the vesting date (from the end of the prior fiscal year) in fair value of option and stock awards granted in any prior fiscal year for which vesting conditions were satisfied during the fiscal year, less the fair value (as of end of prior fiscal year) of prior year awards that failed to vest ^(vi)		5,688,527			823,785
Subtract: Awards granted in prior years that did not meet the applicable vesting conditions during the fiscal year ^(vii)		—			—
Compensation Actually Paid		105,676,083			26,444,391

Non-PEO NEO Average Total Compensation Amount

$ 3,748,508

$ 3,303,421

$ 2,258,387

$ 3,223,063

$ 4,950,600

Non-PEO NEO Average Compensation Actually Paid Amount

$ 2,883,223

3,651,652

2,424,680

(2,680,481)

26,444,391

Adjustment to Non-PEO NEO Compensation Footnote


	FY25						FY24									FY23						FY22
	CEO			Non-PEO NEOs			CEO Mr. Kelderman			CEO Mr. Kummeth			Non-PEO NEOs			CEO			Non-PEO NEOs			CEO			Non-PEO NEOs
Total from Summary Compensation Table ⁽ⁱ⁾		8,151,181			3,748,508			2,636,900	⁽⁶⁾		6,792,945			3,303,421	⁽⁷⁾		30,584,644			2,258,387			15,370,549			3,223,063
Subtract: Grant date fair value of option and stock awards granted in the fiscal year ⁽ⁱⁱ⁾		(5,862,791	)		(1,264,411	)		(2,152,815	)⁽⁶⁾		(5,000,028	)		(1,349,102	)⁽⁷⁾		(29,325,210	)		(850,075	)		(10,299,362	)		(949,840	)
Add: Fair value at fiscal year end of outstanding and unvested option and stock awards granted in the fiscal year ⁽ⁱⁱⁱ⁾		3,511,656			1,569,604			2,344,977			4,234,157			2,565,518			4,318,227	⁽⁸⁾		1,382,025			6,472,546			1,106,688
Add/Subtract: Year-over-Year change in fair value of outstanding and unvested option and stock awards granted in prior fiscal years ^(iv)		(3,442,309	)		(1,234,677	)		—			(1,241,718	)		(847,318	)		(6,132,401	)		(877,492	)		(22,021,635	)		(5,636,997	)
Add: Vesting date fair value of option and stock awards granted and vesting during the fiscal year ^(v)		—			—			—			—			—			—			—			—			—
Add/Subtract: Change as of the vesting date (from the end of the prior fiscal year) in fair value of option and stock awards granted in any prior fiscal year for which vesting conditions were satisfied during the fiscal year, less the fair value (as of end of prior fiscal year) of prior year awards that failed to vest ^(vi)		113,976			64,200			—			36,468			(20,867	)		5,238,918			633,346			4,128,278			469,566
Subtract: Awards granted in prior years that did not meet the applicable vesting conditions during the fiscal year ^(vii)		—			—			—			—			—			—			(121,511	)		—			(892,961	)
Compensation Actually Paid		2,471,713			2,883,223			2,828,450	⁽⁶⁾		4,821,823			3,651,652	⁽⁷⁾		4,684,176			2,424,680			(6,349,624	)		(2,680,481	)


	FY21
	CEO			Non-PEO NEOs
Total from Summary Compensation Table ⁽ⁱ⁾		15,889,896			4,950,600
Subtract: Grant date fair value of option and stock awards granted in the fiscal year ⁽ⁱⁱ⁾		(11,199,803	)		(1,722,395	)
Add: Fair value at fiscal year end of outstanding and unvested option and stock awards granted in the fiscal year ⁽ⁱⁱⁱ⁾		30,362,017			10,602,750
Add/Subtract: Year-over-Year change in fair value of outstanding and unvested option and stock awards granted in prior fiscal years ^(iv)		64,935,446			11,789,651
Add: Vesting date fair value of option and stock awards granted and vesting during the fiscal year ^(v)		—			—
Add/Subtract: Change as of the vesting date (from the end of the prior fiscal year) in fair value of option and stock awards granted in any prior fiscal year for which vesting conditions were satisfied during the fiscal year, less the fair value (as of end of prior fiscal year) of prior year awards that failed to vest ^(vi)		5,688,527			823,785
Subtract: Awards granted in prior years that did not meet the applicable vesting conditions during the fiscal year ^(vii)		—			—
Compensation Actually Paid		105,676,083			26,444,391

Compensation Actually Paid vs. Total Shareholder Return [Text Block]

Compensation Actually Paid vs. Net Income [Text Block]

Compensation Actually Paid vs. Company Selected Measure [Text Block]

Total Shareholder Return Vs Peer Group [Text Block]

Tabular List [Table Text Block]

While we utilized Organic Revenue Growth and Adjusted Net Income in fiscal 2025 as the two performance measures to align executive compensation with performance, Adjusted Net Income is not presented in the “Pay versus performance” table. In accordance with SEC rules, we are providing the following graphic descriptions of the relationships between information presented in the “Pay versus performance” table, as well as between Adjusted Net Income and Company performance.

Total Shareholder Return Amount

$ 79.49

110.17

124.96

132.17

171.17

Peer Group Total Shareholder Return Amount

103.58

131.47

126.72

129.72

147.61

Net Income (Loss) Attributable to Parent

$ 73,400,000

$ 168,105,000

$ 285,442,000

$ 263,099,000

$ 139,585,000

Company Selected Measure Amount

1,210,000

1,147,100

1,134,700

1,113,600

915,900

PEO Name

Mr. Kelderman

Mr. Kummeth

Mr. Kelderman

Mr. Kummeth

Measure [Axis]: 1

Pay vs Performance Disclosure [Table]

Measure Name

Organic Revenue

Non-GAAP Measure Description

(5)	Sales shown reflect organic revenue as calculated for purposes of our executive compensation program for the applicable reporting year. Refer to Appendix A for a reconciliation between GAAP and non-GAAP measures.

Measure [Axis]: 2

Pay vs Performance Disclosure [Table]

Measure Name

Adjusted Net Income

Subtract Grant Date Fair Value Of Option And Stock Awards Granted In The Fiscal Yea [Member] | Non-PEO NEO [Member]